Published in J Clin Immunol on February 02, 2010
TGF-beta: a master of all T cell trades. Cell (2008) 4.60
Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med (2001) 3.10
Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol (2008) 3.05
IL-21 mediates suppressive effects via its induction of IL-10. J Immunol (2009) 2.00
Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet (1993) 1.76
Transforming growth factor-beta: innately bipolar. Curr Opin Immunol (2006) 1.52
Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood (1999) 1.48
Shortage of human intravenous immunoglobulin--reasons and possible solutions. Nat Clin Pract Neurol (2007) 1.35
Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol (2008) 1.35
What is the contents of the magic draft IVIg? Autoimmun Rev (2008) 1.31
Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues. Nat Clin Pract Neurol (2007) 1.28
Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. J Immunol (1999) 1.25
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action. Nat Clin Pract Rheumatol (2007) 1.23
Immunomodulatory action of intravenous immunoglobulin. Immunology (2002) 1.14
Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation. Eur J Immunol (2009) 1.12
Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain. J Immunol (1992) 1.10
Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol (1998) 1.09
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood (2002) 1.08
Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation (1982) 1.03
The antiinflammatory IgG. N Engl J Med (2008) 1.00
Evidence for the use of intravenous immunoglobulins--a review of the literature. Clin Rev Allergy Immunol (2010) 0.99
Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. Lupus (2009) 0.98
Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes. Int Immunol (2000) 0.98
Transforming growth factor-beta1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Blood (2003) 0.96
Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin. Clin Immunol Immunopathol (1994) 0.94
Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol Sci (2003) 0.92
Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity. Eur J Immunol (2009) 0.92
Mediation of enhanced transcription of the IL-10 gene in T cells, upon contact with human glioma cells, by Fas signaling through a protein kinase A-independent pathway. J Immunol (2003) 0.91
Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL. Ann N Y Acad Sci (2007) 0.89
Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations. Tissue Antigens (1992) 0.86
In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion? Transfusion (2001) 0.85
Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin. Transpl Immunol (1994) 0.83
Immunomodulatory effects of blood transfusions: the synergic role of soluble HLA Class I free heavy-chain molecules detectable in blood components. Transfusion (2008) 0.80
IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice. Clin Exp Immunol (2006) 0.80
Soluble human leucocyte antigen-G and interleukin-10 levels in isocyanate-induced asthma. Clin Exp Allergy (2009) 0.79
Posttranscriptional regulation of T-cell IL-2 production by human pooled immunoglobin. Clin Immunol Immunopathol (1997) 0.79
Down-regulation of lymphokine synthesis by intravenous gammaglobulin is dependent upon accessory cells. Scand J Immunol (1998) 0.78
Polyclonal immunoglobulins for intravenous use induce interleukin 10 release in vivo and in vitro. Ann Rheum Dis (2004) 0.78
Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis. Hum Immunol (2009) 0.77
Intravenous immunoglobulins in neurological disorders: safety issues. Neurol Sci (2003) 0.75
[The immunomodulatory effect of blood transfusions and intravenous immunoglobulins: the role of the soluble molecules of the Class-I major histocompatibility complex and of the Fas ligand]. Ann Ital Med Int (2000) 0.75
Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med (2007) 2.94
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol (2004) 1.53
Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroenterol Hepatol (2003) 1.49
BDNF plasma levels variations in major depressed patients receiving duloxetine. Neurol Sci (2014) 1.41
A case of transposition of the great arteries in a female infant of a HIV-1-infected woman. Potential teratogenic effects of antiretroviral drugs. Intern Emerg Med (2006) 1.39
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol (2007) 1.35
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol (2004) 1.32
Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood (2009) 1.19
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood (2002) 1.08
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. Proc Natl Acad Sci U S A (2013) 1.07
Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood (2003) 1.00
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol (2008) 0.99
Transforming growth factor-beta1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Blood (2003) 0.96
Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J Immunol (2005) 0.93
Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-β(1), soluble Fas ligand, and soluble Class I human leukocyte antigen. Transfusion (2011) 0.93
Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity. Eur J Immunol (2009) 0.92
Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors. Pediatr Blood Cancer (2011) 0.89
Changes in neonatal transfusion practice after dissemination of neonatal recommendations. Pediatrics (2010) 0.88
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis. J Rheumatol (2007) 0.87
Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction. ScientificWorldJournal (2002) 0.87
Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation. Blood Transfus (2008) 0.86
Effect of clotting factors concentrates on lymphocyte and neutrophil function in vitro. Thromb Haemost (2003) 0.86
Efficacy of hormonal manipulation in lymphangioleiomyomatosis. A 20-year-experience in 36 patients. Sarcoidosis Vasc Diffuse Lung Dis (2007) 0.86
Near miss errors in transfusion medicine: the experience of the G. Gaslini transfusion medicine service. Blood Transfus (2007) 0.86
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer. Cancer Immunol Immunother (2013) 0.86
Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells. Exp Hematol (2010) 0.85
IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells. PLoS One (2010) 0.84
Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts. Glycobiology (2005) 0.84
Pertussis toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit Tat-induced TGF-beta production by NK cells and TGF-beta-mediated NK cell apoptosis. J Immunol (2005) 0.84
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. Hum Vaccin Immunother (2012) 0.84
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer. Blood (2005) 0.84
NGF serum levels variations in major depressed patients receiving duloxetine. Psychoneuroendocrinology (2013) 0.83
Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways. Br J Pharmacol (2014) 0.83
Rapid growth and regression of intracranial meningiomas in lymphangioleiomyomatosis: case report. Surg Neurol (2007) 0.82
Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment. Clin Exp Rheumatol (2013) 0.82
Miniaturized and high-throughput assays for analysis of T-cell immunity specific for opportunistic pathogens and HIV. Clin Vaccine Immunol (2014) 0.81
Validation of a miniaturized assay based on IFNg secretion for assessment of specific T cell immunity. J Immunol Methods (2010) 0.81
Inflammatory activity is still present in the advanced stages of idiopathic pulmonary fibrosis. Respirology (2005) 0.81
VEGF plasma level variations in duloxetine-treated patients with major depression. J Affect Disord (2013) 0.80
Immunomodulatory effects of blood transfusions: the synergic role of soluble HLA Class I free heavy-chain molecules detectable in blood components. Transfusion (2008) 0.80
Soluble human leukocyte antigen-G serum levels in patients with acquired immune deficiency syndrome affected by different disease-defining conditions before and after antiretroviral treatment. Hum Immunol (2011) 0.79
IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules. Eur J Immunol (2003) 0.79
New approach in vaginal prolapse repair: mini-invasive surgery associated with application of platelet-rich fibrin. Int Urogynecol J (2012) 0.78
Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst (2006) 0.78
Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors. Eur J Immunol (2005) 0.78
Determination of lymphotoxin-alpha levels in patients with psoriatic arthritis undergoing etanercept treatment. J Interferon Cytokine Res (2012) 0.77
Atorvastatin as a trigger of autoimmune hepatitis. J Hepatol (2004) 0.77
Positive selection and expansion of cytomegalovirus-specific CD4 and CD8 T cells in sealed systems: potential applications for adoptive cellular immunoreconstitution. J Immunother (2008) 0.77
Virological and immunological response to antiretroviral regimens containing maraviroc in HIV type 1-infected patients in clinical practice: role of different tropism testing results and of concomitant treatments. AIDS Res Hum Retroviruses (2013) 0.77
Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens. Int Immunopharmacol (2009) 0.77
Apoptotic DNA binds to HLA class II molecules inhibiting antigen presentation and participating in the development of anti-inflammatory functional behavior of phagocytic macrophages. Hum Immunol (2003) 0.77
Detection of cell-free RNA in children with neuroblastoma and comparison with that of whole blood cell RNA. Pediatr Blood Cancer (2010) 0.77
Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome. Hum Immunol (2007) 0.77
Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. Int Immunopharmacol (2008) 0.76
Soluble HLA-G molecule in patients with perennial allergic rhinitis. Int Arch Allergy Immunol (2009) 0.76
A registry of HLA-typed donors for production of virus-specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune-compromised patients. Transfusion (2014) 0.76
Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds. J Affect Disord (2012) 0.76
Paralytic ileus and liver failure--an unusual presentation of advanced erythropoietic protoporphyria. Dig Dis Sci (2008) 0.76
Plasma derivatives and strategies for reaching self-sufficiency in Liguria: the role of the Transfusion Medicine Service of the Gaslini Institute. Blood Transfus (2007) 0.75
Immune homeostasis requires several biologic factors including glucocorticoid hormones. Ann N Y Acad Sci (2002) 0.75
The first case of drug-induced immune hemolytic anemia due to hydrocortisone. Transfusion (2008) 0.75
A sealed and unbreached system for purification, stimulation, and expansion of cytomegalovirus-specific human CD4 and CD8 T lymphocytes. Transfusion (2006) 0.75
Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry. J Chemother (2014) 0.75
Recognition of CMV pp65 protein antigen by human CD4 T-cell lines induced with an immunodominant peptide pool. Hum Immunol (2004) 0.75
A validated LC-MS/MS method for the quantification of piperacillin/tazobactam on dried blood spot. Bioanalysis (2014) 0.75
Soluble human major histocompatibility class I antigens: new immunomodulatory functions for old molecules. Expert Rev Clin Immunol (2006) 0.75
[Mediastinal syndrome: clinical presentation of lymphoma. Report of a case of Hodgkin's lymphoma and a case of non-Hodgkin's lymphoma with similar presentation]. Ann Ital Med Int (2003) 0.75